Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.


Add photos to showcase Geron’s culture


Add Geron’s values

Insider experiences

Share your experience of working at Geron

John A. Scarlett
Chairman, President & CEO
Edward Koval
EVP & Chief Business Officer
Aleksandra Rizo
EVP, Chief Medical Officer
Anil Kapur
EVP, Corporate Strategy & Chief Commercial Officer
Melissa A. Kelly Behrs
EVP, Business Operations & Chief Alliance Officer
Olivia K. Bloom
EVP, Finance, CFO & Treasurer
Stephen N. Rosenfield
EVP, General Counsel & Corporate Secretary

Add your teams to show how people work together at Geron

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.